These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2290478)

  • 1. Carnitine metabolism and morphometric change of liver mitochondria in valproate-treated rats.
    Murakami K; Sugimoto T; Nishida N; Woo M; Araki A; Kobayashi Y; Sakane Y
    Neuropediatrics; 1990 Nov; 21(4):187-90. PubMed ID: 2290478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity in rat following administration of valproic acid.
    Sugimoto T; Woo M; Nishida N; Takeuchi T; Sakane Y; Kobayashi Y
    Epilepsia; 1987; 28(2):142-6. PubMed ID: 3102219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine metabolism in valproate-treated rats: the effect of L-carnitine supplementation.
    Nishida N; Sugimoto T; Araki A; Woo M; Sakane Y; Kobayashi Y
    Pediatr Res; 1987 Nov; 22(5):500-3. PubMed ID: 3120144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity in rat following administration of valproic acid: effect of L-carnitine supplementation.
    Sugimoto T; Araki A; Nishida N; Sakane Y; Woo M; Takeuchi T; Kobayashi Y
    Epilepsia; 1987; 28(4):373-7. PubMed ID: 3113926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of urinary acetylcarnitine in valproate-treated rats: the effect of L-carnitine supplementation.
    Murakami K; Sugimoto T; Nishida N; Woo M; Araki A; Kobayashi Y
    J Child Neurol; 1992 Oct; 7(4):404-7. PubMed ID: 1469250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of valproic acid on the expression of various acyl-CoA dehydrogenases in rats.
    Kibayashi M; Nagao M; Chiba S
    Pediatr Int; 1999 Feb; 41(1):52-60. PubMed ID: 10200137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional study.
    Moreno FA; Macey H; Schreiber B
    J Clin Psychiatry; 2005 May; 66(5):555-8. PubMed ID: 15986510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute valproate administration on carnitine metabolism in mouse serum and tissues.
    Rozas I; Camiña MF; Paz JM; Alonso C; Castro-Gago M; Rodriguez-Segade S
    Biochem Pharmacol; 1990 Jan; 39(1):181-5. PubMed ID: 2105093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine disposition before and during valproate therapy in patients with epilepsy.
    Riva R; Albani F; Gobbi G; Santucci M; Baruzzi A
    Epilepsia; 1993; 34(1):184-7. PubMed ID: 8422857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores.
    Knapp AC; Todesco L; Beier K; Terracciano L; Sägesser H; Reichen J; Krähenbühl S
    J Pharmacol Exp Ther; 2008 Feb; 324(2):568-75. PubMed ID: 17986647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal metabolism of carnitine and valproate in a case of acute encephalopathy during chronic valproate therapy.
    Murakami K; Sugimoto T; Nishida N; Kobayashi Y; Kuhara T; Matsumoto I
    Brain Dev; 1992 May; 14(3):178-81. PubMed ID: 1514659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate, carnitine metabolism, and biochemical indicators of liver function. Collaborative Group for the Study of Epilepsy.
    Beghi E; Bizzi A; Codegoni AM; Trevisan D; Torri W
    Epilepsia; 1990; 31(3):346-52. PubMed ID: 2111771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of administration of anticonvulsant drugs on free carnitine and acylcarnitine in mouse serum and tissues.
    Camiña MF; Rozas I; Gómez M; Paz JM; Alonso C; Rodriguez-Segade S
    Br J Pharmacol; 1991 May; 103(1):1179-83. PubMed ID: 1878756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of L-carnitine supplementation in 4 pentenoic acid treated rats.
    Sugimoto T; Woo M; Nishida N; Araki A; Murakami K; Kobayashi Y
    Brain Dev; 1990; 12(4):417-22. PubMed ID: 2240462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of oxidative phosphorylation in hepatic and cerebral mitochondria of sodium valproate-treated rats.
    Rumbach L; Warter JM; Rendon A; Marescaux C; Micheletti G; Waksman A
    J Neurol Sci; 1983; 61(3):417-23. PubMed ID: 6418862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of D,L-carnitine on valproate-induced hyperammonemia and hypoketonemia in primary cultured rat hepatocytes.
    Takeuchi T; Sugimoto T; Nishida N; Kobayashi Y
    Biochem Pharmacol; 1988 Jun; 37(11):2255-8. PubMed ID: 3132174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the cytotoxicity of sodium valproate on primary cultured rat hepatocytes.
    Takeuchi T; Sugimoto T; Nishida N; Kobayashi Y
    Neuropediatrics; 1988 Aug; 19(3):158-61. PubMed ID: 3146709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
    Chung S; Choi J; Hyun T; Rha Y; Bae C
    J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of renal carnitine metabolism by anticonvulsant treatment.
    Camiña MF; Rozas I; Castro-Gago M; Paz JM; Alonso C; Rodriguez-Segade S
    Neurology; 1991 Sep; 41(9):1444-8. PubMed ID: 1891096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.